Sanders Morris Harris LLC Sangamo Therapeutics, Inc Transaction History
Sanders Morris Harris LLC
- $689 Million
- Q3 2025
A detailed history of Sanders Morris Harris LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Sanders Morris Harris LLC holds 303,000 shares of SGMO stock, worth $172,709. This represents 0.03% of its overall portfolio holdings.
Number of Shares
303,000
Previous 188,500
60.74%
Holding current value
$172,709
Previous $101,000
100.99%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding SGMO
# of Institutions
124Shares Held
51.1MCall Options Held
1.12MPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA9.37MShares$5.34 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.08MShares$4.61 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$3.9 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.68 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$1.33 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $89.2M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...